UNICA IRIS Institutional Research Information System

PERRA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 200.082
NA - Nord America 7.942
AS - Asia 4.061
SA - Sud America 619
AF - Africa 154
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 212.882
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 197.695
US - Stati Uniti d'America 7.786
SG - Singapore 1.536
CN - Cina 1.303
SE - Svezia 510
DE - Germania 480
BR - Brasile 458
VN - Vietnam 405
UA - Ucraina 322
FI - Finlandia 299
GB - Regno Unito 224
FR - Francia 192
HK - Hong Kong 185
CA - Canada 99
IN - India 86
KR - Corea 78
TR - Turchia 71
NL - Olanda 60
ZA - Sudafrica 55
AR - Argentina 51
BD - Bangladesh 49
JP - Giappone 47
PL - Polonia 47
IQ - Iraq 42
MA - Marocco 42
ES - Italia 40
RU - Federazione Russa 38
ID - Indonesia 37
BE - Belgio 36
MX - Messico 33
AT - Austria 32
CO - Colombia 27
PK - Pakistan 25
EC - Ecuador 22
IE - Irlanda 20
IR - Iran 20
AU - Australia 19
UZ - Uzbekistan 19
VE - Venezuela 18
SA - Arabia Saudita 17
CL - Cile 15
LT - Lituania 15
MY - Malesia 15
JO - Giordania 13
KE - Kenya 13
PH - Filippine 12
TH - Thailandia 12
TW - Taiwan 11
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
CZ - Repubblica Ceca 9
IL - Israele 9
PE - Perù 9
AZ - Azerbaigian 8
DZ - Algeria 8
EG - Egitto 8
PA - Panama 8
DK - Danimarca 6
JM - Giamaica 6
KZ - Kazakistan 6
MT - Malta 6
NP - Nepal 6
GE - Georgia 5
LK - Sri Lanka 5
MU - Mauritius 5
TN - Tunisia 5
BG - Bulgaria 4
ET - Etiopia 4
EU - Europa 4
OM - Oman 4
PS - Palestinian Territory 4
PT - Portogallo 4
RO - Romania 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
MK - Macedonia 2
NO - Norvegia 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
SR - Suriname 2
Totale 212.861
Salva come PNG Salva come JPEG
Città #
Cagliari 193.399
Uta 3.615
Ashburn 901
Singapore 900
Fairfield 611
San Jose 553
Dallas 512
Chandler 412
Woodbridge 395
Houston 338
Nyköping 331
Boardman 297
Ann Arbor 261
Beijing 257
Los Angeles 251
Wilmington 246
Seattle 210
Helsinki 202
Cambridge 197
Hong Kong 168
Jacksonville 160
Dearborn 156
Munich 150
New York 131
Santa Clara 122
The Dalles 117
Ho Chi Minh City 112
Shanghai 111
Council Bluffs 98
Hefei 98
Lauterbourg 94
Hanoi 83
Seoul 75
Boston 61
Nanjing 60
Rome 57
Frankfurt am Main 50
São Paulo 49
Buffalo 48
Guangzhou 47
Milan 47
Dong Ket 46
San Diego 46
Chicago 45
London 44
Redwood City 43
Warsaw 39
Toronto 36
Casablanca 35
Redondo Beach 35
Brussels 34
Orem 34
Johannesburg 33
Montreal 33
Turku 33
Tokyo 30
Chennai 29
Kocaeli 29
San Mateo 29
Atlanta 28
Denver 27
Brooklyn 26
Falls Church 26
Nanchang 26
Amsterdam 25
Nuremberg 25
Stockholm 25
Manchester 23
Jiaxing 21
Vienna 21
Shenyang 20
Tianjin 20
Mountain View 19
Phoenix 19
Shenzhen 19
Düsseldorf 18
Rio de Janeiro 18
Da Nang 17
Changsha 16
Dublin 16
Jinan 16
Lappeenranta 16
Minneapolis 16
Paris 16
Tashkent 16
Haiphong 15
Poplar 15
Washington 15
Ankara 14
Augusta 14
Baghdad 14
Leawood 14
Madrid 13
Pisa 13
Biên Hòa 12
Columbus 12
Curitiba 12
Nairobi 12
Norwalk 12
Quito 12
Totale 207.369
Salva come PNG Salva come JPEG
Nome #
null 13.191
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 6.013
α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons 5.812
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.971
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.261
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.235
YAP activation is an early event and a potential therapeutic target in liver cancer development 4.043
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.958
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.875
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.752
Alpha-lipoic acid promotes the growth of rat hepatic preneoplastic lesions in the choline deficient model 3.711
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.709
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.655
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.589
Global gene expression profile of normal and regenerating liver in young and old mice 3.565
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.470
Induction of hepatocyte proliferation by retinoic acid 3.317
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.291
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.183
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.167
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 3.125
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.092
THYROID HORMONE RECEPTORS DOWNREGULATION IS AN EARLY EVENT AND IS MAINTAINED ALLACROSS THE STEP-BY-STEP PROCESS OF HEPATOCARCINOGENESIS 2.986
The thyromimetic KB2115 (Eprotirome) induces rat hepatocyte proliferation 2.973
Wnt/beta-catenin pathway is activated by thyroid hormone and is required for its hepatomitogenic activity 2.956
ALFA-LIPOIC ACID ENHANCES CHOLINE DEFICIENT DIET-INDUCED FATTY LIVER AND STEATOHEPATITIS, AND PROMOTES THE GROWTH OF PRENEOPLASTIC LESIONS IN RAT LIVER. POSTER EASL 2.921
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.909
Thyroid hormone receptors downregulation is an early event and is maintained all across the step-by-step process of hepatocarcinogenesis. 2.813
NRF2 mutations are frequent in early rat preneoplastic hepatic lesions and in human hepatocellular carcinomas positive for the stem/progenitor cell marker KRT-19 2.781
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.767
Progenitor-derived hepatocellular carcinoma model in the rat 2.745
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.734
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.651
Timed regulation of P-element-induced wimpy testis-interacting RNA expression during rat liver regeneration 2.643
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair 2.636
IMPACT OF KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS ON PROGRESSION OF HEPATOCELLULAR CARCINOMA 2.596
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression 2.555
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes 2.509
Induction of pancreatic acinar cell proliferation by thyroid hormone 2.474
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 2.461
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis 2.436
Role of natural killercells receptors on the development and progression of hepatocellularcarcinoma 2.416
null 2.399
Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes 2.387
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene 2.377
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.329
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.206
Cell proliferation induced by 3,3',5 triiodo L thyronine is associated with a reduction in the number of preneoplastic hepatic lesions 2.114
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 2.019
Cytokeratin-19, a predictive marker and an early determinant of progenitor-derived hepatocellular carcinoma 2.012
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.907
Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma 1.784
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas 1.763
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.685
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.666
Early metabolic changes in a liver carcinogenesis model 1.497
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.457
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.442
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.347
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.315
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.227
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.216
Early Metabolic Changes in preneoplastc nodules of the liver 1.174
Hepatic stellate cell: a star cell in the liver 1.124
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G 1.090
Non-Invasive Detection of a De Novo Frameshift Variant of STAG2 in a Female Fetus: Escape Genes Influence the Manifestation of X-Linked Diseases in Females 1.061
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 964
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 963
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 922
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 895
COVID-19 Vaccine Hesitancy among Italian Healthcare Workers: Latent Profiles and Their Relationships to Predictors and Outcome 894
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 867
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 850
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 836
Amoxicillina-acido clavulanico ed anticoagulanti orali:un’associazione potenzialmente pericolosa 824
Decision trees for early prediction of inadequate immune response to coronavirus infections: a pilot study on COVID-19 823
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose 754
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 745
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity 728
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 695
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 671
Inhibitory effect of thyroid hormone (T3) on the development of rat hepatocellular carcinoma. POSTER 653
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 606
Morphological alterations of the lung in the Sickle Cell Trait 597
Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration 544
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic 531
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 516
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 513
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy 474
Alpha lipoic acid promotes preneoplastic growth in rat liver. POSTER 23° Meeting of German Association for the Study of Liver (GASL), Gottingen 466
Analysis of pathological findings in a humanized murine model of sickle cell anemia 459
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 458
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 456
α-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patients 450
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 427
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 421
Editorial: Targeting Thyroid Hormone-Dependent Pathways in Proliferative and Degenerative Disorders 406
Morphological investigation of endothelial and sub-endothelial alterations associated with sickle cell trait in a mouse model 404
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 368
Electron microscopy investigation of the Townes mouse spleen: an example of Translational Anatomy 363
Totale 211.088
Salva come PNG Salva come JPEG
Categoria #
all - tutte 256.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 256.780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.211 0 0 0 0 0 0 0 0 0 2.419 2.441 1.351
2021/202210.543 1.481 750 419 752 937 661 455 434 1.189 1.105 1.233 1.127
2022/202316.318 1.073 2.121 2.240 1.383 1.260 1.700 902 940 1.116 1.236 1.499 848
2023/202416.202 1.026 678 893 923 1.442 2.416 2.610 1.407 687 990 1.364 1.766
2024/202537.531 11.399 12.112 3.543 3.185 1.523 1.947 2.254 207 332 297 318 414
2025/20269.611 661 513 986 894 891 695 2.831 460 591 1.089 0 0
Totale 213.281